EDU-12683-37107
2 vaccinations
4 coded responses
24 check-ins
4 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 834 / ID
- Registered
- 2021-01-14
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-14
Registered in v-safe
-
2021-01-14
Dose 1 — Moderna
- 2021-01-14
-
2021-01-15
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Redness · Muscle or body aches, Abdominal painAdult check-in
- 2021-01-16
- 2021-01-17
-
2021-01-18
Survey response — days 1–6 daily, dose 1MedDRA: Condition aggravated, Pre-existing disease — Feeling: Good · Fatigue or tirednessFree text: I have already been diagnosed with an autoimmune disorder. Previously I was in remission and this has changed since my vaccination but I was likely due for another flareMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-19
- 2021-01-21
-
2021-01-28
Survey response — day 14, dose 1MedDRA: Injection site mass, Injection site pain, Injection site warmth — Feeling: Good · Be unable to do your normal daily activitiesFree text: I developed a lump or thickness in my arm muscle where I received the injection. It was hot to the touch and tender for about 2 days. I used heat compresses and massage until it resolved. It has returned to normal nowMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-04
-
2021-02-11
Dose 2 — Moderna
- 2021-02-11
-
2021-02-12
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
- 2021-02-14
- 2021-02-15
- 2021-02-16
- 2021-02-17
- 2021-02-18
- 2021-02-25
- 2021-03-04
- 2021-03-11
- 2021-03-18
- 2021-03-25
-
2021-05-13
Survey response — 3 months, dose 2MedDRA: Rash — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Some type of rash. It seems unrelated to my vaccineMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-13
Report sent to call center — 3 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-08-12
Survey response — 6 months, dose 2MedDRA: Urticaria pressure — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Diagnosed with delayed pressure urticariaMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-12
Report sent to call center — 6 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-08-17
Call successfulParticipant prefers to complete VAERS report online
- 2022-02-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-14 | Moderna | |
| 2 | 2021-02-11 | Moderna |
Call center
2 call center cases
2 successful
Free text
Release 2 — days 1–6 daily, dose 1
Systemic reaction (other): I have already been diagnosed with an autoimmune disorder. Previously I was in remission and this has changed since my vaccination but I was likely due for another flare
Release 2 — day 14, dose 1
Symptoms: I developed a lump or thickness in my arm muscle where I received the injection. It was hot to the touch and tender for about 2 days. I used heat compresses and massage until it resolved. It has returned to normal now
Release 8 — 3 months, dose 2
Symptoms: Some type of rash. It seems unrelated to my vaccine
Release 9 — 6 months, dose 2
Symptoms: Diagnosed with delayed pressure urticaria
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Injection site mass | ✓ | ✓ | ✓ |
| SD | Injection site pain | ✓ | ✓ | ✓ |
| SD | Injection site warmth | ✓ | ✓ | ✓ |
| SD | Rash | ✓ | ✓ | ✓ |
| SD | Urticaria pressure | ✓ | · | ✓ |
| SRO | Condition aggravated | ✓ | ✓ | ✓ |
| SRO | Pre-existing disease | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release